Supernus Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Abbott USD 7.62B 58M 2024-12
ANI Pharmaceuticals USD 144.86M 121K 2024-12
Aurora Cannabis CAD 108.71M 23.79M 2024-12
Bristol-Myers Squibb USD 10.35B 2.46B 2024-12
Canopy Growth CAD 16.31M 69.8M 2024-12
Corcept Therapeutics USD 127.66M 9.62M 2024-12
Eisai JPY 291.26B 22.65B 2024-12
Eli Lilly USD 3.27B 100.6M 2024-12
Indivior 288M 14M 2024-09
Pacira USD 276.77M 30.81M 2024-12
Perrigo USD 558.8M 904.7M 2024-12
Pfizer USD 1.04B 49M 2024-12
Supernus Pharmaceuticals USD 69.33M 37.66M 2024-12
United Therapeutics USD 1.7B 143.3M 2024-12
Xeris Pharmaceuticals USD 71.62M 12.39M 2024-12



Supernus Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.